efs.sante.fr The best blood donor and blood product for each patient: an evolving role for haemovigilance? Pierre Tiberghien Etablissement Français du
|
|
- Darcy Washington
- 5 years ago
- Views:
Transcription
1 The best blood donor and blood product for each patient: an evolving role for haemovigilance? Pierre Tiberghien Etablissement Français du Sang, St-Denis Université de Franche-Comté, Besançon France
2
3
4
5
6 Transfusion thresholds A large number of studies have highlighted that low/restrictive (vs high/liberal) RBC transfusion thresholds in most clinical settings are not only not associated with increased morbidity or mortality, but may possibly associated with improved outcome.
7 Transfusion thresholds A large number of studies have highlighted that low/restrictive (vs high/liberal) RBC transfusion thresholds in most clinical settings are not only not associated with increased morbidity or mortality, but may possibly associated with improved outcome. Clinicaltrials comparing the effects of restrictive versus liberaltransfusion on 30-day mortality (Carson et al, NEJM, 2017) Despite these findings, insuring adequate hemoglobin thresholds for RBC transfusion through education and reporting of deviation to appropriate guidelines are not presently a mainstay of a majority of hemovigilance programs.
8 Thresholds require specificity. NEJM, patients with severe acute upper gastrointestinal bleeding and randomly assigned to a restrictive strategy (transfusion when the hemoglobin level fell below 7 g per deciliter) or a liberal strategy (transfusion when the hemoglobin fell below 9 g per deciliter) Kaplan Meier estimates of the 6-week survival rate in the two groups. The probability of survival was significantly higher in the restrictive-strategy group than in the liberal-strategy group. The gray arrows indicate the day on which data from a patient were censored. The inset shows the same data on an enlarged y axis.
9 NEJM, children with sickle cell anemia randomized to receive regular blood transfusions (transfusion group) or standard care (observation group). Conclusion: regular blood-transfusion significantly reduced the incidence of recurrence of cerebral infarct in children with sickle cell anemia.
10
11 Critical Care, 2010 Physiologic transfusion triggers should progressively replace arbitrary Hb-based transfusion triggers. Goal-directed erythrocyte transfusions to promote and optimize therapeutic adequacy while saving blood and avoiding unwanted adverse effects These physiologic transfusion triggers can be based on signs and symptoms of impaired global (lactate, SvO2 or ScvO2) or, even better, regional tissue (such as EKG ST-segment or P300 latency) oxygenation as well as heart rate and mean arterial pressure or systolic arterial pressure.
12 Critical Care, 2010 Physiologic transfusion triggers should progressively replace arbitrary Hb-based transfusion triggers. Goal-directed erythrocyte transfusions to promote and optimize therapeutic adequacy while saving blood and avoiding unwanted adverse effects These physiologic transfusion triggers can be based on signs and symptoms of impaired global (lactate, SvO2 or ScvO2) or, even better, regional tissue (such as EKG ST-segment or P300 latency) oxygenation as well as heart rate and mean arterial pressure or systolic arterial pressure.
13 Vox Sanguinis, 2017 The provision of such assessment tools as well as their implementation under the surveillance and reporting by hemovigilance is essential to assess current blood products safety with regard to donor, product and recipient characteristics.
14 Vox Sanguinis, 2017 The provision of such assessment tools as well as their implementation under the surveillance and reporting by hemovigilance is essential to assess current blood products safety with regard to donor, product and recipient characteristics.
15 Less sophisticated, but essential: bleeding assessment Bleeding assessment in at-risk (central thrombocytopenia, massive bleeding, ) patients receiving blood products is most often not within hemovigilance surveillance
16 Transfusion, 2018 Curr Op Hematol, 2016
17 Transfusion, 2018 Curr Op Hematol, 2016 Whole-blood transfusion is associated with improved or comparable survival compared with acute life bleeding resuscitation with blood components while greatly facilitating transfusion logistics Furthermore, platelet-containing blood products stored at 4 C have superior hemostatic function, compared with platelet-containing blood products at 22 C.
18 NEJM, 2008
19 NEJM, patients were assigned to receive fresh red cells (freshblood group) and 1219 patients were assigned to receive standard-issue red cells (standard-blood group
20 NEJM, patients were assigned to receive fresh red cells (freshblood group) and 1219 patients were assigned to receive standard-issue red cells (standard-blood group
21 Vox Sanguinis, 2017
22 Hypothesis as to why short-term blood storage could be harmful (Ning et al, Transfusion Med Rev, 2017)
23 Lancet Haematol, 2017
24 Lancet Haematol, 2017
25 Lancet Haematol, 2017
26 NEJM, 2015
27
28 Vox Sanguinis, 2011
29 Vox Sanguinis, 2011
30 Could anti-hyimmunity in female donors exposed to male antigens during pregnancy could be contributive? Anti-H-Y immunity (Nielsen et al, Human Reproduction, 2010) H-Y antigens are encoded by a number of genes on the Y chromosome and are ubiquitously expressed by male cells (Warren et al, 2000) Maternal immune recognition of H-Y antigens can be demonstrated in women following pregnancies with boys (Verdijk et al, 2004). Allogeneic hematopoietic cell transplantation (HCT) recipients of parous female grafts are more prone to develop graft-versus-host disease (GvHD) than recipients of either nulliparous female grafts or male grafts (Kollmanet al, 2001; Loren et al,2006). This increased risk of GvHDis believed to be due to the frequent development of a cytotoxic immune response against H-Y antigens (Gratwohlet al, 2001). H-Y antibodies also develop significantly more often in male recipients with female donors compared with male recipients of male donors (Miklos et al., 2004, 2005), and the presence of the H-Y antibodies correlates with chronic GvHD.
31 Human Reproduction, 2010 Birth of a boy is significantly more common than a girl prior to secondary recurrent miscarriage. High frequency of H-Y antibodies is found in women with secondary recurrent miscarriage. The presence of such antibodies in early pregnancy is associated with low number of male offspring Frequency of H-Y immunity in blood donors? Transfer of anti-h-y cellular immunity despite deleucocytation? Transfer of a sufficient amount of anti-h-y antibodies? capable of inducing long-term immuno-pathology?
32 JAMA, patients who received RBC transfusions exclusively from 1 of 3 types of donors (88% male; 6% ever-pregnant female; and 6% never-pregnant female)
33 JAMA, patients who received RBC transfusions exclusively from 1 of 3 types of donors (88% male; 6% ever-pregnant female; and 6% never-pregnant female) The highest HRs for death after transfusion of RBC from ever-pregnant female donors were observed in male recipients 50 years and younger
34 JAMA Int Med, 2016
35 JAMA Int Med, 201è transfusion recipients (Scandinavian donations and transfusions database) Hazard ratio of death: o Unadjusted model: o U-shaped association between age of the blood donor and recipient mortality, with a nadir in recipients for the most common donor age group (40-49 years) and increasing HRs among recipients of blood from donors of successively more extreme age groups o Higher mortality among recipients of blood from female donors o Adjusted model for number of transfusions with a linear term: o attenuated but persisting associations between donor age / gender and mortality Closer examination of the association between number of transfusions and mortality revealed a nonlinear pattern. After adjustments to accommodate nonlinearity, donor age and sex were no longer associated with patient mortality.
36 Additional statistical adjustment needed to accurately account for the non linear association between mortality risk and the total number of transfused blood products Adjustingwitha linearterm: distorsion for «rare» caracteristics? Impact on «no-mixture» or «single» blood studies cohort studies?
37 Similarly, a smaller study involving transfused cardiac surgery patients did not find an effect of donor sex (and storage duration) on outcome Transfusion, cardiac surgery patients no significant effect of storage duration or donor sex.
38
39
Blood transfusions in ICU: double-edged sword. Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal
Blood transfusions in ICU: double-edged sword Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal Canadian Critical Care Trials Group Collaborating for Impact Leading
More informationTransfusion triggers in acute coronary syndromes: The MINT trial
Transfusion triggers in acute coronary syndromes: The MINT trial Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal Objectives Review evidence on transfusion triggers
More informationDelayed hemolytic transfusion reaction in the French hemovigilance system
Delayed hemolytic transfusion reaction in the French hemovigilance system C. Rieux, G. Brittenham, D. Bachir, E. De Meyer, K. Boudjedir for the French hemovigilance network First Seminar on delayed hemolytic
More informationMorris A. Blajchman, MD, FRCP(C) Emeritus Professor, McMaster University Hamilton, Ontario, CANADA
Morris A. Blajchman, MD, FRCP(C) Emeritus Professor, McMaster University Hamilton, Ontario, CANADA RBC TRANSFUSIONS: GENERAL PRINCIPLES RBCs are usually dispensed on a first-in, first-out basis. Storage
More informationRationale for RBC Transfusion in SCD
Rationale for RBC Transfusion in SCD Dilution of HgbS-containing RBCs via the addition of HgbA-containing cells from the blood of normal donors Suppression of erythropoietin release caused by the rise
More informationBlood Transfusion Guidelines in Clinical Practice
Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationPatient Blood Management: Enough is Enough
Patient Blood Management: Enough is Enough Richard Benjamin, MBChB, PhD, FRCPath Professor of Pathology Georgetown University Medical Center Washington, D.C. Chief Medical Officer Cerus Corporation Concord,
More informationAnticipating (re)emerging infections to ensure blood safety
Anticipating (re)emerging infections to ensure blood safety Pierre Tiberghien Etablissement Français du Sang, St-Denis and Université de Franche-Comté, Besançon, France IPFA/PEI 23rd International Workshop
More informationRed Cell Transfusion triggers: A moving target When, who, and how much?
Red Cell Transfusion triggers: A moving target When, who, and how much? Tim Walsh Professor of Critical Care, Edinburgh University A transfusion threshold of 70 g/l or below, with a target Hb range of
More informationLiberale versus restriktive EK-Transfusion
SWISSTRANSFUSION 2016 Thursday, August 25, 2016; 11:00 11:30 am Liberale versus restriktive EK-Transfusion Reto Schüpbach Dokumentenname Datum Seite 0 Pull out, you hit the artery! www.pinterest.com Dokumentenname
More informationMASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE
MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE CONTENTS Definition Indications Transfusion trigger Massive transfusion protocol Complications DEFINITION Massive transfusion:
More informationTransfusion Requirements and Management in Trauma RACHEL JACK
Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension
More informationPEDIATRIC TRANSFUSION MEDICINE AS A SUB-SPECIALITY TO TRANSFUSION MEDICINE
PEDIATRIC TRANSFUSION MEDICINE AS A SUB-SPECIALITY TO TRANSFUSION MEDICINE Prof. Neelam Marwaha MD; FAMS; FISHTM. Head, Dept. of Transfusion Medicine PGIMER Chandigarh Dr. Hari Krishan Dhawan MD. Assistant
More informationSpecific Requirements
Specific Requirements AIMS Specific requirements your patients have for transfusion and how this is managed Classify which patients require: Irradiated components CMV negative components Washed components
More informationLifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.
LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual
More informationOneMatch Stem Cell and Marrow Network. Training Guide
OneMatch Stem Cell and Marrow Network Training Guide What is OneMatch all about? OneMatch is a Canadian Program that matches and coordinates the collection of stem cells from potential donors to help save
More informationTransfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015
Transfusion Medicine Potpourri BUMC - Phoenix Internal Medicine Residents September 29, 2015 Clinical case A 24 year old female with sickle cell anemia has just moved to the area and presents as a new
More informationRed blood cell transfusions in the PICU: What & When
Red blood cell transfusions in the PICU: What & When Canada Critical Care Forum November 8th 2018 Toronto, CA Marisa Tucci and Jacques Lacroix Pediatric Intensive Care Sainte-Justine University Hospital
More informationRBC Transfusion
RBC Transfusion 2014년혈액종양내과춘계연수강좌 Won SikLee, M.D., Ph.D. Division of Hemato-Oncology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital 2014. 06. 21. Background
More informationBONE MARROW PERIPHERAL BLOOD Erythrocyte
None Disclaimer Objectives Define anemia Classify anemia according to pathogenesis & clinical significance Understand Red cell indices Relate the red cell indices with type of anemia Interpret CBC to approach
More informationAn Approach to the Patient Refractory to Platelets Transfusion. Harold Alvarez, MD
Harold Alvarez, MD Objectives Explain the etiology of platelet refractoriness Discuss the different types of platelet refractoriness Describe how platelet refractoriness is diagnosed Discuss different
More informationBlood Component Therapy
Blood Component Therapy Dr Anupam Chhabra Incharge-Transfusion Medicine Pushpanjali Crosslay Hopital NCR-Delhi Introduction Blood a blood components are considered drugs because of their use in treating
More informationGoal Directed Therapy : Liberal vs Restrictive Transfusion.. Syafri Kamsul Arif
Goal Directed Therapy : Liberal vs Restrictive Transfusion. Syafri Kamsul Arif Sepsis Perioperative EGDT PGDT PGDT Protocol Stroke volume optimization with fluid protocol SVV or PPV based GDT Protocol
More informationBlood Components & Indications for Transfusion. Neda Kalhor
Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets
More informationThree decades of transfusion Toronto, Critical Care Canada Forum, October 30, 2014.
Three decades of transfusion Toronto, Critical Care Canada Forum, October 30, 2014. Jacques Lacroix For the Canadian Critical Care Trials Group and the PALISI Network Pediatric Intensive Care Unit Sainte-Justine
More informationDr Marina Karakantza Consultant Haematologist, NHSBT
Dr Marina Karakantza Consultant Haematologist, NHSBT Overview Definition of transfusion thresholds Mechanisms of adaptation to anaemia How RBC transfusion affect adaptation mechanisms to anaemia Triggers
More informationTransfusion Indications: Update in 2019
Transfusion Indications: Update in 2019 Yulia Lin, MD, FRCPC, CTBS Division Head, Transfusion Medicine, Sunnybrook HSC Associate Professor, Dept of Laboratory Medicine and Pathobiology, University of Toronto
More informationChest diseases Hospital Laboratory Hematology Practice guidelines
Chest diseases Hospital Laboratory Hematology Practice guidelines Title RBCs transfusion in Adults SOP Code Policy Owner Hematology Unit Section Hematology Prepared By Dr. Taher Ahmed Abdelhameed Issuing
More informationBlood Transfusion Project. Reducing Transfusion in the MARCQI Population
Blood Transfusion Project Reducing Transfusion in the MARCQI Population Anemia in Healthy Awake Volunteers Critical hemoglobin threshold unknown in humans At 6 g/dl Decline in cognitive function At 5 g/dl
More informationTransfusions in Acute Care Too Little?
Transfusions in Acute Care Too Little? Keyvan Karkouti MD FRCPC MSc Associate Professor Department of Anesthesia; Department of Health Policy, Management, and Evaluation; University of Toronto Scientist
More informationAdvances in Transfusion and Blood Conservation
Advances in Transfusion and Blood Conservation Arman Kilic, MD Division of Cardiac Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD No relevant financial relationships to disclose.
More informationTransfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components
Objectives Transfusion Pitfalls Gregory W. Hendey, MD, FACEP Professor and Chief UCSF Fresno, Emergency Medicine To list risks and benefits of various blood products To discuss controversy over liberal
More informationTrends in Hematopoietic Cell Transplantation. AAMAC Patient Education Day Oct 2014
Trends in Hematopoietic Cell Transplantation AAMAC Patient Education Day Oct 2014 Objectives Review the principles behind allogeneic stem cell transplantation Outline the process of transplant, some of
More informationHematopoietic Stem Cell Transplant in Sickle Cell Disease- An update
Hematopoietic Stem Cell Transplant in Sickle Cell Disease- An update Dr Chirag A Shah Diplomate American Board of Hematology and Medical Oncology Director, Dept of Hemato-Oncology and Stem Cell Transplant
More informationBlood transfusions in sepsis, the elderly and patients with TBI
Blood transfusions in sepsis, the elderly and patients with TBI Shabbir Alekar MICU, CH Baragwanath Academic Hospital & The University of the Witwatersrand CCSSA Congress 11 June 2015 Packed RBC - complications
More informationLookback studies to assess viral risks The French experience
Lookback studies to assess viral risks The French experience 2000-2012 S Laperche 1, MF Leconte des Floris 2, J Pillonel 3, L Hauser 2, C Lefort 2, JY Py 2, I Hervé 2, R Djoudi 2 For the French haemovigilance
More informationNicole Laferriere MD PhD FRCPC April 10, Patient Case Studies: Sticky Situations For Platelet Transfusions
Nicole Laferriere MD PhD FRCPC April 10, 2019 Patient Case Studies: Sticky Situations For Platelet Transfusions Disclosures Ad Board: Celgene, Jansen, Takeda, Roche, Sanofi, Leo, Shire, Servier, Phizer,
More informationExam 3 Study Guide. 4) The process whereby the binding of antibodies to antigens causes RBCs to clump is called:
Exam 3 Study Guide 1) Where does hematopoiesis produce new red blood cells: 2) Which of the following is a blood clotting disorder: 3) Treatment of hemophilia often involves: 4) The process whereby the
More informationTransfusion in Sickle Cell Disease What the guidelines [are likely to] say. Dr Bernard Davis Whittington Hospital, London
Transfusion in Sickle Cell Disease What the guidelines [are likely to] say Dr Bernard Davis Whittington Hospital, London Background to BCSH Guideline Rationale Current guidance in disparate publications
More informationJOURNAL CLUB INDICATIONS FOR AND ADVERSE EFFECTS OF RED CELL TRANSFUSION. Maggie Woods PGY-3
JOURNAL CLUB INDICATIONS FOR AND ADVERSE EFFECTS OF RED CELL TRANSFUSION Maggie Woods PGY-3 BACKGROUND Objective: To describe evidence for current guidelines, review trends, examine the risks of transfusion
More informationTransfusion for the sickest ICU patients: Are there unanswered questions?
Transfusion for the sickest ICU patients: Are there unanswered questions? Tim Walsh Professor of Critical Care Edinburgh University None Conflict of Interest Guidelines on the management of anaemia and
More informationEVIDENCE BASED RED CELL TRANSFUSION. Rana Samuel, MD DIRECTOR, PATHOLOGY AND LABORATORY MEDICINE VA WNY Health Care System
EVIDENCE BASED RED CELL TRANSFUSION Rana Samuel, MD DIRECTOR, PATHOLOGY AND LABORATORY MEDICINE VA WNY Health Care System HISTORY Blood transfusion works (ie: red cell transfusion saves lives). based on
More informationHB TRIGGER & SINGLE UNITS
HB TRIGGER & SINGLE UNITS Conflict of Interest Disclosure I hereby declare the following potential conflicts of interest concerning my presentation: Consultancy: none Research Funding: 2 RCTs funded by
More informationCarol Cantwell Blood Transfusion Laboratory Manager St Mary s Hospital, ICHNT
Carol Cantwell Blood Transfusion Laboratory Manager St Mary s Hospital, ICHNT History Why is blood transfusion involved? What tests are performed in blood transfusion and why? What does a protocol look
More informationAllogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section:
Medical Policy Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Type: Medical Necessity and Investigational / Experimental Policy Specific Section:
More informationSupplementary Online Content
Supplementary Online Content Rohde JM, Dimcheff DE, Blumberg N, et al. Health care associated infection after red blood cell transfusion. JAMA. doi:10.1001/jama.2014.2726 etable 1. Search Strategy etable
More informationBlood Types and Genetics
Blood Types and Genetics Human blood type is determined by codominant alleles. An allele is one of several different forms of genetic information that is present in our DNA at a specific location on a
More informationCrossmatching and Issuing Blood Components; Indications and Effects.
Crossmatching and Issuing Blood Components; Indications and Effects. Alison Muir Blood Transfusion, Blood Sciences, Newcastle Trust Topics Covered Taking the blood sample ABO Group Antibody Screening Compatibility
More informationOverview of session. Blood transfusions in advanced disease 3/21/18. Why am I interested in blood transfusions?
Blood transfusions in advanced disease Dr Karen Neoh Registrar in Palliative Medicine, Leeds Teaching Hospital Trust and the Academic Unit of Palliative Care, University of Leeds Dr Jason Boland Senior
More informationEarly Goal-Directed Therapy
Early Goal-Directed Therapy Where do we stand? Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpital Cochin & Institut Cochin, Paris-F Resuscitation targets in septic shock 1 The
More informationControversies in Transfusion Medicine
Controversies in Transfusion Medicine Jeffrey L. Carson, M.D. Richard C. Reynolds Professor of Medicine Chief, Division of General Internal Medicine Robert Wood Johnson Medical School New Brunswick, New
More informationThinking Twice About Transfusions: When TACOS and TRALIs Turn Treatment Into Tragedy. Megan Boysen Osborn, MD, MHPE
Thinking Twice About Transfusions: When TACOS and TRALIs Turn Treatment Into Tragedy Megan Boysen Osborn, MD, MHPE Let s TACO bout Transfusion Reactions Megan Boysen Osborn, MD, MHPE Let s TACO bout Transfusion
More informationMassive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD
Massive Transfusion MPQC Spring Summit April 29, 2015 Roger Belizaire MD PhD Take home points 1. Blood is always available. Requests for massive transfusion or emergency release typically only require
More informationTransfusion Triggers. Richard Soutar January 2012
Transfusion Triggers Richard Soutar January 2012 1 Educational objectives: To understand the risks of transfusion - the known, the uncertain and unknown To understand the fear of the unknown in Transfusion
More informationBlood and Marrow Transplant (BMT) for Sickle Cell Disease
Blood and Marrow Transplant (BMT) for Sickle Cell Disease Rhiannon is now cured of sickle cell disease after BMT. Blood and marrow transplant (BMT) is a proven cure for sickle cell disease. This handbook
More informationHemovigilance in France
Hervé P. et al Rev.bras.hematol.hemoter., 2000, 22(3): 368-373 Special Article Hemovigilance in France Patrick Hervé 1, 2 Marie-Françoise L. des Floris 2 Danielle Rebibo 1 Pascal Morei 2 Georges Andreu
More informationCirculation and Blood
Circulation and Blood Circulation A circulatory system usually consists of: 1) A in which materials are ( ) 2) A network of or body spaces in which the fluid flows ( ) 3) A means of driving or moving the
More informationComposition of Blood
Composition of Blood Erythrocytes Disorders of Erythrocytes Hematocrit Leukocytes Disorders of Leukocytes Platelets Hemostasis Disorders of Clotting Blood Types Blood Transfusion Unit 7 Blood Composition
More informationRed-blood-cell alloimmunization and number of red-blood-cell transfusions
ORIGINAL PAPER ª 2011 The Author(s) Vox Sanguinis ª 2011 International Society of Blood Transfusion DOI: 10.1111/j.1423-0410.2011.01517.x Red-blood-cell alloimmunization and number of red-blood-cell transfusions
More informationEarly-goal-directed therapy and protocolised treatment in septic shock
CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) 164 168! The Intensive Care Society 2014 Reprints and permissions:
More informationHaplo vs Cord vs URD Debate
3rd Annual ASBMT Regional Conference for NPs, PAs and Fellows Haplo vs Cord vs URD Debate Claudio G. Brunstein Associate Professor University of Minnesota Medical School Take home message Finding a donor
More informationBone Marrow Transplantation
Bone Marrow Transplantation Introduction Bone marrow is the spongy tissue inside all of your bones, including your hip and thigh bones. The bone marrow is like a factory that makes different types of blood
More informationWhat You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014
What You Need to Know About Blood Transfusion Elianna Saidenberg May 2014 Objectives Why your doctor might order transfusion therapy Where does the blood come from The beginning of your transfusion Consent
More informationTransplants. Mickey B. C. Koh
Transfusion in Stem Cell Transplants Mickey B. C. Koh Director: Stem Cell Transplant Programme Department of Haematology, St. George s Hospital and Medical School, London, UK Medical Director: Cell Therapy
More information12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization
Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,
More informationEarly Management of the Patient with Acute GI Bleeding
Early Management of the Patient with Acute GI Bleeding Dr Sarah Hearnshaw Consultant Gastroenterologist Newcastle upon Tyne NHS Trust Go through.. Stats Transfusion / resuscitation PPIs When to call us
More informationCIRCULATORY SYSTEM TASK CARDS Worksheet
CIRCULATORY SYSTEM TASK CARDS Worksheet Name: Date: Instructions: Put the answers to each task card in the numbered boxes on the chart. 1 a) left semilunar valve / aortic valve b) blood would backflow
More informationA closer look at BLOOD Lab
A closer look at BLOOD Lab Name Synthetic by Part 1 a drop of blood White Cell Plasma Platelet White Cell Background: All blood will contain Red Cells (RBC), White Cells (WBC), and Platelets. The number
More informationChapter 19. Blood Types
Chapter 19 Blood Types What is an antigen? Antigens are glycoprotein and glycolipid molecules which are part of the plasma membrane (i.e. part of the glycocalyx) These molecules maybe imbedded into the
More informationDonation from Old Living Donors How safe is it? Safe for recipient or donor?
Donation from Old Living Donors How safe is it? Safe for recipient or donor? Pr Lionel Rostaing Service de Néphrologie, Hémodialyse, Aphérèses et Transplantation CHU Grenoble Alpes France lrostaing@chu-grenoble.fr
More informationCTYOMEGALOVIRUS (CMV) - BACKGROUND
CTYOMEGALOVIRUS (CMV) - BACKGROUND PURPOSE The flowing information provides guidance on the use of CMV negative blood components provided by the blood bank at the Royal Children s Hospital (RCH) including
More informationUK Liver Transplant Audit
November 2012 UK Liver Transplant Audit In patients who received a Liver Transplant between 1 st March 1994 and 31 st March 2012 ANNUAL REPORT Advisory Group for National Specialised Services Prepared
More informationAlister Jones Patient Blood Management Practitioner NHS Blood and Transplant. Lab Matters study day Oake Manor, Taunton, 8 th July 2015
Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant Lab Matters study day Oake Manor, Taunton, 8 th July 2015 NPSA Rapid Response Report 2010 Transfusion of blood and blood components
More informationb) List the steps that may occur in hemostasis with a brief explanation of what happens in those steps.
UNIT 6: CARDIOVASCULAR SYSTEM 1) List the three general functions of BLOOD. REVIEW QUESTIONS Blood 2) a) What are the three formed elements /cellular elements in blood (use anatomy vocabulary)? b) List
More informationHaematology and Transfusion
Haematology and Transfusion dr.w.engelhardt@gmail.com Wolfram Engelhardt Offenburg, Germany James Blundell 1828 Diameter 6-8 µm Erythrocytes Women: Men: 4-5 x 10 6 /µl 5-6 x 10 6 /µl live 100-120 days
More informationHow we View & Approach TACO
How we View & Approach TACO Annual Blood Transfusion & Hemovigilance Symposium Ede, Netherlands May 22, 3014 Mark A. Popovsky, M.D. Chief Medical Officer, Haemonetics Corporation Associate Clinical Professor,
More informationDonatore HLA identico di anni o MUD giovane?
Donatore HLA identico di 60-70 anni o MUD giovane? Stella Santarone Dipartimento di Ematologia, Medicina Trasfusionale e Biotecnologie Pescara AGENDA 1. Stem Cell Donation: fatalities and severe events
More informationFluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE
Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE In critically ill patients: too little fluid Low preload,
More informationBoot Camp Transfusion Reactions
Boot Camp Transfusion Reactions Dr. Kristine Roland Regional Medical Lead for Transfusion Medicine, VCH Objectives By the end of this session, you should be able to: Describe in common language the potential
More informationTransfusion-associated graft-versus-host disease
CHAPTER 6 Transfusion-associated graft-versus-host disease Eric A. Gehrie, 1 Edward L. Snyder, 1 & Alex B. Ryder 2 1 Department of Laboratory Medicine, Yale School of Medicine, Yale University; and Blood
More informationHU: Myths and Facts. Melanie Kirby Associate Professor of Paediatrics
HU: Myths and Facts Melanie Kirby Associate Professor of Paediatrics SACGO Hamilton, Ontario March 5, 2016 Declaration of Disclosure I have no actual or potential conflict of interest in relation to this
More informationCHAPTER 10 BLOOD GROUPS: ABO AND Rh
CHAPTER 10 BLOOD GROUPS: ABO AND Rh The success of human blood transfusions requires compatibility for the two major blood group antigen systems, namely ABO and Rh. The ABO system is defined by two red
More informationImmunohematology (Introduction)
Modified from Serotonin version Immunohematology (Introduction) References: -Blood Groups and Red Cell Antigens (Laura Dean) -Cellular and molecular immunology, 8 th edition Introduction to replace blood
More informationPre-hospital Administration of Blood Products (PHBP) and Tranexamic acid (TXA): Is the Jury Still Out?
Pre-hospital Administration of Blood Products (PHBP) and Tranexamic acid (TXA): Is the Jury Still Out? Jessica K. Reynolds, MD Assistant Professor of Surgery University of Kentucky, Department of Trauma
More informationPatient Blood Management: At the Forefront of Quality and Value in Healthcare
Patient Blood Management: At the Forefront of Quality and Value in Healthcare Ryan A. Metcalf, MD, CQA(ASQ) Associate Medical Director, University Hospital Transfusion Services and ARUP Blood Services
More informationThe Value of Community- Based Initiatives
The Value of Community- Based Initiatives Saving Lives Through Blood and Marrow transplantation Jeffrey Chell, MD 1 What is Bone Marrow? The blood-forming cells in the hollow portion of our bones Looks
More informationYear in Review: Critical Care Medicine
Year in Review: Critical Care Medicine No disclosures Eric J. Seeley, M.D. Assistant Professor of Medicine Division of Pulmonary and Critical Care Medicine Why I Selected These Studies High quality studies
More informationTransfusion Practices and Creation of a Registry for Patients with Sickle Cell Disease within the Atlanta Sickle Cell Consortium
Transfusion Practices and Creation of a Registry for Patients with Sickle Cell Disease within the Atlanta Sickle Cell Consortium Annie Winkler MD Assistant Professor, Emory University Department of Pathology
More informationHaemoglobinophaties EBMT 2011 Data Manager session
Haemoglobinophaties EBMT 2011 Data Manager session Presentation plan Biological characteristics Clinical characteristics Transplant resuts What is different From transplant in malignancies Between Thalassemia
More informationPatient Blood Management Are you providing this? Jeannie Callum, BA, MD, FRCPC Associate Professor, University of Toronto
Patient Blood Management Are you providing this? Jeannie Callum, BA, MD, FRCPC Associate Professor, University of Toronto Disclosures Relevant relationships with commercial entities: Octapharma, CSL Behring
More informationTransfusion and Blood Stream Infections after Coronary Surgery
1 Transfusion and Blood Stream Infections after Coronary Surgery Tuomas Tauriainen, a Eeva-Maija Kinnunen, a Idamaria Laitinen, a Vesa Anttila, b Tuomas Kiviniemi, b Juhani K.E. Airaksinen, b and Fausto
More informationGUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS
CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.
More informationDefining the clinical need for Rare Blood. Vered Yahalom MD Deputy director & Medical director NBGRL Magen David Adom National Blood Services Israel
Defining the clinical need for Rare Blood Vered Yahalom MD Deputy director & Medical director NBGRL Magen David Adom National Blood Services Israel Issues Addressed Defining Rare Blood (ISBT WP on Rare
More informationBlood transfusion and intestinal perfusion in preterm infants Narendra Aladangady
Blood transfusion and intestinal perfusion in preterm infants Narendra Aladangady MD, FRCPCH, PhD Consultant Neonatologist Hon Clinical Professor in Child Health History of blood transfusion First report
More informationBlood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?
What is blood transfusion? A blood transfusion is a safe, common procedure in which blood is given through an intravenous (IV) line in one of the blood vessels. A blood transfusion usually takes two to
More informationBlood Management 2016
Blood Management 2016 2016 AAHKS Annual Meeting Orthopaedic Team Member Course Harpal S. Khanuja, MD Associate Professor Chief of Adult Reconstruction Johns Hopkins University Chair, Johns Hopkins Bayview
More informationBlood Typing * OpenStax. 1 Antigens, Antibodies, and Transfusion Reactions
OpenStax-CNX module: m46708 1 Blood Typing * OpenStax This work is produced by OpenStax-CNX and licensed under the Creative Commons Attribution License 4.0 By the end of this section, you will be able
More informationBLOOD TRANSFUSION. Dr Lumka Ntabeni
BLOOD TRANSFUSION Dr Lumka Ntabeni Blood transfusion definition SAFE transfer of BLOOD COMPONENTS from a DONOR to a RECEPIENT CONTENT Brief history of blood transfusion How is safety guaranteed? How do
More information